- Home
- GTX vs APGE Comparison
GTX vs APGE Comparison
Compare GTX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTX | APGE |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GTX | APGE |
|---|---|---|
| Price | $29.07 | $134.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $20.40 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 20.63 | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $3,584,000,000.00 | N/A |
| Revenue This Year | $4.16 | N/A |
| Revenue Next Year | $3.27 | N/A |
| P/E Ratio | $60.98 | ★ N/A |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $12.26 | $34.34 |
| 52 Week High | $36.25 | $134.46 |
Technical Indicators
Market Signals| Indicator | GTX | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 79.52 |
| Support Level | $17.30 | $80.52 |
| Resistance Level | $32.69 | N/A |
| Average True Range (ATR) | 1.16 | 0.30 |
| MACD | -0.31 | -1.71 |
| Stochastic Oscillator | 20.95 | 68.18 |
Price Performance
Historical ComparisonAbout GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.